For Medicare Drug Cost Suits, Final Price Could Be Key
Drugmakers and industry groups arguing that the Medicare drug price negotiation program amounts to an unconstitutional taking of their property have an uphill battle, and experts say their claims can be...To view the full article, register now.
Already a subscriber? Click here to view full article